What if you invested $1000 in DGX on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Quest Diagnostics Incorporated has delivered an average annual return of 9.2%. The stock peaked in 2021 with a massive +45.5% gain, while investors faced a downturn in 2018 (-14.2%). Overall, the stock finished in the green 15 times out of 20 years.
Avg Return
+9.2%
Win Rate
75%
15W - 5L
Best
+45.5%
2021
Worst
-14.2%
2018
Performance Consistency
About Quest Diagnostics Incorporated
Visit Website ↗Quest Diagnostics is a leading American clinical laboratory and a critical infrastructure provider in the U.S. healthcare system, offering a wide range of diagnostic information services. The company provides comprehensive diagnostic testing, information, and services to patients, physicians, hospitals, and health plans.
Key Business Segments
Diagnostic Information Services
Provides a full range of routine and specialized diagnostic testing, including esoteric testing, anatomic pathology, and genetic testing.
Key Innovations
- ✓Pioneered in providing more accurate and affordable outpatient diagnostic testing, making essential healthcare services more accessible.
- ✓Developed a broad portfolio of diagnostic tests and services, including highly specialized genetic testing and advanced Alzheimer's diagnostics.
Historical Milestones
Quest Diagnostics is founded as Metropolitan Pathology Laboratory, Inc. (MetPath) by Dr. Paul A. Brown.
The company is spun off from Corning Inc. to become an independent, publicly traded company, Quest Diagnostics.
Quest Diagnostics acquires SmithKline Beecham Clinical Laboratories, significantly boosting its market share and testing capabilities.
Launches QuestDirect, allowing consumers to order lab tests directly without a physician's visit.